74-year-old male, AF and previous ablation of typical flutter, CHA2DS2-VASc, hematological high priority indication for Ibrutinib (high bleeding and pro-AF risk).

4 April 2022 (08:42 - 08:54)
Organised by:
Congress Presentation Part of: Difficult decisions in rhythm control of atrial fibrillation (AF) Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2022